Assessment of a New Food Product in Metabolically at Risk Children

NCT ID: NCT03175003

Last Updated: 2019-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-06-15

Study Completion Date

2018-05-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current study conducted will lend toward the optimization of the development of a food product that will promote a shift towards improved metabolic health. Specifically, this trial will determine the optimal level of protein needed to elicit positive changes in markers of inflammation, metabolic and micronutrient status, hepatic lipid metabolism, vascular function, and the relationship of these changes to the metabolome in school aged children (9 - 13 years of age).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Each participant will be asked to participate in a screening and 2 study intervention visits. Each intervention visit will include anthropometric measures, complete the education component, vascular function tests, and a blood draw and spot urine. The screening visit will confirm the child's eligibility for study enrollment and will serve to acclimate the child to the vascular function, and physical activity measurements. The remaining 2 visits will be scheduled 4 weeks apart. The participants will also be provided and asked to wear a physical activity monitor, which in addition to tracking physical activity, will also be used to incorporate a nutrition education program. The parent/guardian will be asked to help with providing the child the daily food product and to help their child fill out the compliance log. Volunteers will also be sought for stool and saliva collection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Risk Factor Inflammation Micronutrient Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Double blind, controlled, 4 parallel arm design
Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators
Products will look and taste similar, and will be provided in coded packaging

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Food Product 1

Macronutrient similar to experimental, micronutrient lower than experimental

Group Type ACTIVE_COMPARATOR

Food Product

Intervention Type OTHER

Each food product will provide similar calories, but a different micro- and macro-nutrient composition

Food Product 2

Macronutrient lower than experimental, micronutrient similar to experimental

Group Type ACTIVE_COMPARATOR

Food Product

Intervention Type OTHER

Each food product will provide similar calories, but a different micro- and macro-nutrient composition

Food Product 3

Experimental 1

Group Type EXPERIMENTAL

Food Product

Intervention Type OTHER

Each food product will provide similar calories, but a different micro- and macro-nutrient composition

Food Product 4

Experimental 2

Group Type EXPERIMENTAL

Food Product

Intervention Type OTHER

Each food product will provide similar calories, but a different micro- and macro-nutrient composition

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Food Product

Each food product will provide similar calories, but a different micro- and macro-nutrient composition

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or Female 9-13 years old
* Subject is willing and able to comply with the study protocols
* Subject is willing to consume the test products
* Access to a smart phone or tablet at least 1x / week; and willing to download a free applications associated with the study

Exclusion Criteria

* Allergies or intolerances to peas, legumes, pulses, soy, dairy or wheat/gluten
* Under current medical supervision
* Tanner Score = 4
* Non-English speaking
* Current participation in a daily exercise routine of moderate or high intensity
* Self-reported presence of disease, a history of serious illness, or who are currently under acute medical care.
* Currently taking prescription drugs or supplements
* Any supplement use, including multi-vitamin/ mineral, herbal, plant or botanical, fish oil, and oil supplements.
* Self-reported malabsorption or gastrointestinal issues
* Current enrollee in a clinical research study.
Minimum Eligible Age

9 Years

Maximum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Davis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carl L Keen, PhD

Role: PRINCIPAL_INVESTIGATOR

Principal Investigator

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Nutrition

Davis, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1009239

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.